JD Health Collaborates with Stakeholders to Build a Scientific Weight Management Ecosystem Amid Soaring Industry Demand

Since 2025, the topic of “weight management” has frequently trended on social media. While the “weight loss economy” has gained significant momentum, experts caution that weight loss is fundamentally a matter of health management, and unscientific methods and approaches can pose risks to health.

On April 8, the “2025 JD Health Weight Management Industry Summit” was held in Beijing. Under the theme “Scientific Weight Loss for a Healthier Future,” the event brought together numerous industry experts, pharmaceutical company representatives, and relevant practitioners to jointly explore development trends and innovative practices in the professional field of “weight management.”

At the conference, JD Health, in collaboration with pharmaceutical companies, medical institutions, and industry associations, launched the “Initiative for Co-building a Scientific Weight Management Ecosystem.” The initiative advocates for the establishment of a comprehensive service system spanning “prevention, diagnosis and treatment, and management,” jointly responding to the policy requirements of the “Implementation Plan for the ‘Year of Weight Management’ Campaign.” It aims to provide efficient, accessible, and professional multi-tiered health management solutions for China’s overweight and obese population, driving the industry toward a new stage of standardized development and intelligent management.

 JD Health Joins Forces with Multiple Parties to Launch Initiative for Co-Building a Scientific Weight Management Ecosystem

Obesity has become a global health challenge. The latest data from the National Health Commission shows that more than half of the adult population faces weight-related health issues, and even more concerning is that this problem is trending towards younger age groups. Driven by both high policy attention and growing public health needs, weight management is ushering in historic development opportunities.

In the field of weight management, the rapid market launch and stable supply of innovative drugs are key to addressing patient needs. Leveraging its robust supply chain infrastructure, JD Health continues to strengthen its position as the premier platform for the nationwide debut of new and specialized pharmaceuticals. By providing mature launch solutions, JD Health accelerates the omni-channel expansion of novel weight-loss medications, offering patients access to cutting-edge treatment regimens that are synchronized with global standards.

Leveraging its nationwide network of 20 pharmaceutical cold-chain warehouses, JD Health has established a drug distribution network covering more than 400 cities. Through full-process temperature-controlled monitoring and real-time tracking technologies, the company ensures that every link in the supply chain for popular weight-loss medications such as semaglutide and tirzepatide remains secure and controlled from manufacturing to delivery. In first-tier cities across China, JD Health’s cold-chain drug delivery can achieve arrival within as little as two hours, significantly enhancing the timeliness and convenience of medication access.

Meanwhile, JD Health has continued to deepen its collaborations with renowned pharmaceutical companies both domestically and internationally. By adopting a “direct supply from manufacturers” model, it minimizes intermediaries, thereby ensuring drug quality and stable supply. In terms of channel coverage, JD Health integrates B2C e-commerce, O2O instant retail, and its offline self-operated pharmacy resources, allowing users to flexibly choose among online ordering, in-store pickup, or home delivery services. Particularly in lower-tier markets, leveraged by its robust supply chain network, fulfillment efficiency for users in county-level areas and below has significantly improved, enabling patients in remote regions to rapidly access innovative medicines.

Weight management is not merely about changing the numbers on a scale; it is about reshaping one’s lifestyle for better health. Centered on its closed-loop, end-to-end service model of “medical consultation + testing + diagnosis + medication,” JD Health provides users with a more convenient, scientific, and professional one-stop weight management solution.

JD Internet Hospital has leveraged top-tier physician resources across China to promptly launch a Weight Management Clinic. It integrates a multidisciplinary team of specialists from Grade A tertiary hospitals, including experts in endocrinology, cardiology, gastroenterology, traditional Chinese medicine, nutrition, and pediatric endocrinology, along with a dedicated team of full-time registered dietitians. This comprehensive professional service model delivers scientific weight management tailored to individual constitutions, health status, and weight loss goals. Services encompass the entire care continuum—from risk assessment and personalized plan development to medication guidance and regular follow-ups—ensuring a safe and healthy weight loss journey. Since its launch, the Weight Management Clinic has served over 10,000 patients, with many achieving scientifically guided weight loss and a user satisfaction rate of 99%.

JD Daojia’s rapid testing service has also launched the “Semaglutide Companion Six-Panel Medication Test,” providing more convenient at-home testing services for users utilizing GLP-1 receptor agonists for weight loss. Professional nurses perform home blood draws, with sample collection completed in as little as one hour, thereby ensuring medication safety. Through this closed-loop service model, JD Health has achieved full-process coverage from consultation to testing and from diagnosis to medication management, creating a one-stop health management experience for users.

In terms of service capacity building, JD Health also places particular emphasis on user education and health science popularization, disseminating thematic education on “weight management science” through short videos, live streaming, and other formats to enhance public health awareness.

Furthermore, JD Health has developed differentiated solutions tailored to specific population groups. For instance, for adolescents in school settings, JD Health provides professional medical consultations and scientific dietary guidance; for working professionals, it integrates exercise planning and nutritional supplementation into fragmented time slots; and for the elderly, it emphasizes health monitoring and long-term weight management. Through these services, JD Health is committed to delivering comprehensive, personalized, and scientifically grounded weight management support to every user.

Technology empowerment is the key driver propelling weight management into a new phase. Currently, JD Health is leveraging its self-developed “Jingyi Qianxun” medical large language model to inject intelligent capabilities into its weight management services.

Among these, the application of large language model technologies in AI-driven physicians, pharmacists, and nutritionists has not only enhanced service efficiency but also delivered personalized weight management solutions for users. From risk assessment to intervention implementation, and from outcome monitoring to long-term maintenance, AI technology makes weight management more precise, efficient, and intelligent.

At the event, JD Health also invited Qu Shen, a standing committee member of the Chinese Society of Endocrinology and Director of the Institute of Obesity at Tongji University School of Medicine, along with medical experts from Peking University First Hospital and China-Japan Friendship Hospital, to engage in a roundtable discussion on long-term obesity management, the construction of scientific weight-loss systems, and future trends. The experts unanimously agreed that scientific weight loss should be integrated into daily life to form a sustainable health management model. A representative from JD Health stated that the company will provide users with more professional, personalized, and sustainable scientific weight management solutions in the future, helping them achieve healthy weight management grounded in overall well-being.

From left to right: Qu Shen, Standing Committee Member of the Endocrinology Branch of the Chinese Medical Association and Director of the Institute of Obesity at Tongji University School of Medicine; Guo Xiaohui, Chief Physician in the Department of Endocrinology at Peking University First Hospital; Hong Jing, Chief Physician in the Department of Endocrinology at China-Japan Friendship Hospital; Dou Pan, Associate Chief Physician in the Department of Clinical Nutrition at Peking University First Hospital; Fan Hui, Vice President of JD Group and General Manager of the Internet Healthcare Business Unit at JD Health.

In another roundtable discussion themed “Breakthroughs in Pharmaceutical Innovation: Full-Cycle Care from Weight Management to Metabolic Health,” representatives from pharmaceutical companies such as Innovent Biologics, Xianweida Biopharma, and Yinuo Biotech, along with JD Health, engaged in in-depth discussions on topics including innovative drug R&D, challenges in clinical translation, and the empowerment of internet healthcare. A representative from JD Health stated that the company is currently enhancing drug accessibility for pharmaceutical enterprises by strengthening its intelligent supply chain, building a comprehensive disease management system, and deepening the application of AI technologies, while also providing more specialized services for promotion and user management.

From left to right: Tan Yong, Vice President of the China Pharmaceutical Enterprise Management Association; Pan Hai, Founder, Chairman, and CEO of Xianweida Biologics; Yu Dechao, Founder, Chairman, and CEO of Innovent Biologics Group; Wang Qinghua, Founder, Chairman, and CEO of Yinnuo Medicine; Song Zhirui, Vice President of JD.com and General Manager of the Pharmaceutical Business Department of JD Health

At the conference, JD Health also launched the “Initiative for Co-building a Scientific Weight Management Ecosystem,” calling for active alignment with the policy requirements of the “Implementation Plan for the ‘Year of Weight Management’ Campaign.” The initiative aims to establish a comprehensive service system covering “prevention–diagnosis and treatment–management,” promote industry standardization by developing tiered diagnosis and treatment standards, drive service model upgrades through accelerated data integration and AI application innovation, and build a multi-tiered safeguard system to jointly foster a national health ecosystem.

Looking ahead, JD Health will continue to deepen its supply chain advantages, further strengthen its professional service capabilities, and actively promote technological innovation. Taking this conference as a starting point, it will join hands with industry partners to explore new models and pathways for weight management, build a more open, collaborative, and win-win health ecosystem, and jointly create a benchmark for scientific weight loss services.